ketanserin has been researched along with Pulmonary Arterial Remodeling in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with ketanserin attenuated bleomycin-induced PH (increased RVSP and RVH) and pulmonary vascular remodeling (decreased vessel density and increased muscularization of small vessels)." | 1.48 | Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice. ( Delaney, C; Fisher, S; Maltzahn, J; Nozik-Grayck, E; Sherlock, L; Wright, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delaney, C | 1 |
| Sherlock, L | 1 |
| Fisher, S | 1 |
| Maltzahn, J | 1 |
| Wright, C | 1 |
| Nozik-Grayck, E | 1 |
1 other study available for ketanserin and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice.
Topics: Animals; Animals, Newborn; Antibiotics, Antineoplastic; Bleomycin; Bronchopulmonary Dysplasia; Hyper | 2018 |